Annual Report 1968-69

Total Page:16

File Type:pdf, Size:1020Kb

Annual Report 1968-69 ANNUAL REPORT 1968-69 Chemical Laboratory, Poona NATIONAL CHEMICAL LABORATORY POONA 1968-1969 COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH CONTENTS INTRODUCTION SPONSORED PROJECTS PRIVATE PARTIES INTERMEDIATES AND DYES 1. Anthraquinonoid intermediates and dyes I TERPENOIDS 2. Utilization of longifolene and63-carene I 3. Isolation of borneol I 4. Utilization of isolongifolene 2 DRUGS AND PHARMACEUTICALS 5. Carbimazolc 2 6. Mcgimide 2 7. Sorbidc nitrate 3 8. Sulphacetamide and its sodium salt 3 9. 8-Hydroxyquinoline 3 10. Radio-opaque dyes 3 PERFUMERY CHEMICALS II. p-Phenethyl alcohol 4 12. Preparation of perfumery grade geraniol, citronellal and citronellol from Indian lemongrass oil 4 MISCELLANEOUS 13. Analysis of organic compositions of industrial importance 4 I 14. Screening of NCL compounds by Bristol Laboratories, Syracuse, (N. Y.) for pharmaco- logical activity 4 15. Steroids and wax from sugarcane press-mud 5 16. Development of adhesives for decorative laminates 5 17. Technical preparation of liquid stabilizer for PVC 5 18. Technical preparation of pentachlorophenol and other chlorophenolic compounds 5 19. Development of an infra-red spectrophotometer 6 CENTRAL AND STATE GOVERNMENT INSTITUTES 20. Composite drug research scheme on Indian medicinal plants 6 21. Fabrication of Electron Diffraction Camera 7 22. Constitution of lac 7 23. Lac dye 8 24. Titanium tetrachloride from ilmenite 9 25. Pulping of Kashmir soft woods 9 PL-480 SCHEMES 26. Chemical and thermodynamic properties of refractory matcrials at high temperatures 9 27. Work on the synthesis and properties of new type glycol monoalkyl ethers for the control of water evaporation to extend the industrial utilization of cotton seed oil 12 28. Investigation of the effect of heat on tung oil and derivatives of tung oil and the chara­ cterization and identification of compounds rcsulting from heat treatment to extend the utilization of tung oil 13 II 29. Wood phenolics with special reference to their use in chemolaxonomy and their biosynthesis by tissue culture studies 14 PILOT PLANTS 1. Aniline 17 2. Industrially useful products from polysaccharides 17 3. Phthalates 18 4. Technical preparations of organic intermediates 18 5. Fine Chemicals Project 19 PRODUCT ORIENTED RESEARCH 1. Cadmium sulphide photoconductive cells 20 2. Tin oxide resistor 20 3. Ferroelectric materials 21 4. Posistors 21 5. Polycrystalline silicon 22 6. Ferrite compositions 22 7. Potential Catalyst materials 23 7*1 Alumina 23 7*2 Molecular sieves 23 8. Silicones and silicone intermediates 24 9. Ethyl silicate 25 10. Burning of TiCI4 in oxygen to produce rutile titania 25 11. Polytetraf luoro ethylene 26 ni 12. Butyl titanate 26 13. Utilization of some mineral concentrates 27 14. Preparation of magnesium and magnesium calcium silicate for thermal insulation 28 15. Chromatographic adsorbents and other chemicals 28 16. Aluminium silicate as rubber filler 29 17. Aluminium hydroxide gel 29 18. Di-o-tolylbiguanide 29 19. Dyes for synthetic fibres 29 20. Technical preparations of organophosphorous compounds 30 20-1 Triethyl phosphate 30 20-2 Tris-nonylphenyl phosphite 30 20-3 Trioctyl phosphate 30 20-4 Triphcnyl phosphate 31 21. Simazine 31 22. Hydroxyethylstarch 31 23. Saccharification of cellulose 31 24. Cellulose powder 32 25. Synthetic glycosides and other synthetic carbohydrate materials 32 25-1 Glycosides and thioglycosides 32 25 * 2 Phenolphthalein-D-glucuronide 32 IV 26. N-acetylneuraminic acid 33 27. Substitute for gum arabic 33 28. Cashewnut shell gum 34 29. Vitamin B0 34 30. N, N-diethyl-raeta-toluamide 34 31. Colchicine 34 32. Terpin hydrate and terpineol 35 33. Allantoin 35 34. para-Nitrophenol 35 35. para-Acetylsulphanyl chloride 36 36. 19-Norsteroids and other modified steroids 36 37. Preparation of photosensitive chemicals 36 37-1 2:3-Dihydroxynaphthalene-6-sulphonic acid 36 37-2 Light sensitive stabilized diazonium salts 36 38. Theophylline — caffeine 37 39. para-tert-Butylcatechol 37 40. Catechol 37 41. 2-Aminopyrimidine and sulphadiazine 38 42. Purification of anthracene 38 43. Acetylacetone 39 44. Stationary liquid phases and solid support for GLC instruments 39 45. Conversion of dehydrocostus lactone into chamazulene and s-guaiazulene 39 46. Phenobarbitone 40 47. Salicylaldehyde 40 48. Stabilized gel for hot and cold sachets 40 49. Acrylic base cation exchange resin 41 50. Polystyrene foams 41 51. Sulphochlorinated polyethylene 41 52. Nitrile rubber 42 53. Rubberized cork sheets 42 54. Polysulphide rubber 43 55. Utilization of coir pith 43 56. Latex foam backed coir 43 57. Rubber reclaiming agents 43 58. Rubber blowing agents 44 59. Styrenated alkyds 44 60. Linseed oil emulsions 44 61. Coating for nylon fabric 45 62. Leather coatings 45 63. Resins for automobile filters 45 64. Isocyanate-based coatings 45 65. Diamond setting cement 46 VI 66. Rubber base adhesives * • 46 67. Materials for artificial limbs • • 46 68. Composite propellents 46 69. Sealants for canvas bags . 47 70. Synthetic polymers for oil well drillings • • 47 71. Synthetic polymer for cane juice clarification 47 72. Utilization of a bye-product available in the manufacture of terephthalic acid • • 48 73. Micro filters • * 48 74. Xylene formaldehyde resins 48 75. Foundry chemicals 48 75* 1 Shell moulding resin 48 75-2 Sinol core binder 49 75-3 Dry core binder 49 75*4 Starch phosphate 49 75-5 Double boiled linseed oil substitute . 49 76. Low temperature fluxes 50 77. Substitute for dextrin • • 50 78. ChlorobeHzenes * * 50 79. Ethylenediamine • • 51 80. Chlorination of methane gas 51 81. Ethyl acetoacetate • * 52 VII 82. Preparation of sorbitol and mannitol from invert sugar • • 83. Phenacetin • • 84. Analytical vapour phase chromatograph • • 85. Preparative vapour phase chromatograph • • 86. ESR spectrometer • • 87. Self balancing strip-chart recorder • • 88. Fabrication of a precision ultrasonic interferometer • * 89. Equipment for the determination of total solid content in latex compositions, cements and adhesives • • RESEARCH PROJECTS 1. Theoretical investigations in solid state • • I • 1 The ligand field theory of trigonal bipyramidal complexes • • 2. Materials for solid state devices • - 2-1 Ferroelectric materials • * 2*2 Chalcogenide spinel semiconductors * * 2-3 Metal-insulator-metal sandwiches • * 2-4 Photoconducting materials • • 2-5 Magnetic properties of decomposition products of iron oxalates • • 3. Nuclear and radiation chemistry * • vni 3-1 Studies on MOssbauer effect 59 3*2 Hydroxylation of aromatic hydrocarbons by radiolysis 60 3 • 3 Diffusion of rare earth metals in copper 60 4. Thermodynamic studies 62 4 • 1 Thermodynamic properties of solutions 62 4-2 Thermodynamics of metal ion complex formation in solutions 62 5. Thin films 63 5-1 Structure of thin films 63 5 • 2 Physics of thin films 64 6. Crystal and molecular studies 65 6 • 1 Crystallography 65 6-2 Spectrochemical studies 65 7. Synthetic inorganic chemistry 66 66 7 • 1 Titanium and tin organics 66 7*2 Coordination compounds 7-3 Fluorine chemistry 68 8. Physico analytical chemistry 68 8-1 New reaction of analytical importance 68 9. Natural organic products 70 9 * 1 Utilization of p-himachalene 70 9 • 2 Celastrus paniculatus 70 IX 9 • 3 Utilization of bye-products of opium alkaloid industry 70 9*4 Oleorcsins and resinoids 71 9 • 5 Chemical investigation of Shoma arabica 71 9 • 6 Mucopolysaccharides 71 9-7 Codextrmization of some indigenous gums and other polysaccharides 72 9-8 Chemical examination of Vetivaria zizanoides 72 9*9 Synthetic experiments on berberine alkaloids 73 9* 10 Structure of salvin and picrosalvin 73 9-11 Nimbinin and related products 73 9*12 Conformational studies 74 10. Synthetic organic chemistry 74 10 • 1 4-Acetomethylcoumarines 74 10*2 Synthetic studies in 4-arylcinnolincs and 2-arylquinoxalines 74 10-3 Transformation products of carvonc and limonenc 75 10-4 Transformation products of costunolide * • 76 10-5 Synthesis of compounds related to selinane, 77 elemane and p-menthane • .• 77 10-6 Chemical transformations of dehydrocostus lactone 78 10-7 Synthesis of sarkomycin • • 78 10-8 Transformation products of eudesmol * • 78 10-9 Flavonoids • • x 10* 10 Naturally occurring anthraquinone pigments * • 79 10-11 NMR spectra of anthrones . 79 10* 12 Zinc dust distillation of hydroxyanthraquinoncs carrying methyl groups - * 79 10-13 Tetrahydroxyanthraquinones • • 80 10*14 Synthesis of colucidin • • 80 10-15 Studies in synthetic dyes • - 80 10-16 Studies in heterocyclic compounds • * 82 10-17 Antifertility drugs 85 11. Physical organic chemistry • • 87 11-1 Mass spectrometry • - 87 11-2 Studies on conjugated systems • • 88 12. Microbiology 91 12-1 National Collection of Industrial Microorganisms 91 12-2 Production of mutants 92 12-3 Microbiolog cal transformation of terpenes 92 13. Growth of plant cells 93 14. Enzymes • * 94 14-1 Hexokinase 94 14-2 Phytase * • 94 14-3 DPNase 95 14-4 Acetylcholinesterase 95 14-5 Acylphosphatase • • 96 XI 14-6 Metabolism of nitrate by Achromobacter fischeri 96 14-7 Citrate-oxaloacetate lyase (Citrase) 97 14-8 DFP-Susceptible enzymes and antidotes 97 14-9 Enzymes and the metabolism of organic acids 98 15. Physico chemical studies on polymers 98 15-1 Stereo specific polymerization 98 15*2 Degradation of long chain molecules by ultrasonics 99 16. Chemical engineering studies 99 16-1 Design cell 99 16*2 Fluidization 99 16-3 Mass transfer 100 16-4 Diffusion in solid catalyst 100 16-5 Reaction models and reactor design 101 16-6 Distillation 101 16-7 Development of a continuous process for the preparation
Recommended publications
  • Review Article SOME PLANTS AS a SOURCE of ACETYL CHOLINESTERASE INHIBITORS: a REVIEW Purabi Deka *, Arun Kumar, Bipin Kumar Nayak, N
    Purabi Deka et al. Int. Res. J. Pharm. 2017, 8 (5) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 – 8407 Review Article SOME PLANTS AS A SOURCE OF ACETYL CHOLINESTERASE INHIBITORS: A REVIEW Purabi Deka *, Arun Kumar, Bipin Kumar Nayak, N. Eloziia Division of Pharmaceutical Sciences, Shri Guru Ram Rai Institute of Technology & Science, Dehradun, India *Corresponding Author Email: [email protected] Article Received on: 27/03/17 Approved for publication: 27/04/17 DOI: 10.7897/2230-8407.08565 ABSTRACT The term dementia derives from the Latin demens (“de” means private, “mens” means mind, intelligence and judgment- “without a mind”). Dementia is a progressive, chronic neurological disorder which destroys brain cells and causes difficulties with memory, behaviour, thinking, calculation, comprehension, language and it is brutal enough to affect work, lifelong hobbies, and social life. Alzheimer’s disease, Parkinson’s disease, Dementia with Lewys Bodies are some common types of dementias. Acetylcholinesterase AChE) Inhibition, the key enzyme which plays a main role in the breakdown of acetylcholine and it is considered as a Positive strategy for the treatment of neurological disorders. Currently many AChE inhibitors namely tacrine, donepezil, rivastigmine, galantamine have been used as first line drug for the treatment of Alzheimer’s disease. They are having several side effects such as gastrointestinal disorder, hepatotoxicity etc, so there is great interest in finding new and better AChE inhibitors from Natural products. Natural products are the remarkable source of Synthetic as well as traditional products. Abundance of plants in nature gives a potential source of AChE inhibitors. The purpose of this article to present a complete literature survey of plants that have been tested for AChE inhibitory activity.
    [Show full text]
  • Pdate Roduct
    Environmental Analysis Analytical Chemistry Standard 2002 No.3 Dioxin Endocrine Air Pollutant Water Solvents Chromatography Indicator JCSS Wetting Ultratrace Supramolecular Spectrochemical pdate U :20:32 roduct P ako W WakoPureChemical KYOSHINSHA Title:ProUpNo3/表紙訂正分 Page:1 Date: 2003/06/06 Fri 17 KYOSHINSHA Title:ProUpNo3/表紙訂正分 Page:2 Date: 2003/06/06 Fri 17:20:34 Index ENVIRONMENTAL ANALYSIS • Wakopak® Fluofix 1. Dioxins Analysis • Wakopak® Combi CN A. Multilayer Silica Gel Column Chromatography ................... 1 • Wakogel DX (Silica Gel) (238-01781) B. Reagents for Ion Pair Chromatography (IPC) ...................... 9 • Sodium Sulfate (194-12221) • Tetra-n -butylammonium Phosphate Soln. (207-13701) • Decane (048-28543, 042-28541) • 1-Pentanesulfonic Acid Sodium Salt Soln. (169-18231) • Ethanol (99.5) (056-06663, 050-06661) • 1-Hexanesulfonic Acid Sodiom Salt Soln. (086-07141) • Nonane (148-07351, 142-07354) • 1-Heptanesulfonic Acid Sodium Salt Soln. (083-07151) • Petroleum ether (160-20231) • 1-Octanesulfonic Acid Sodium Salt Soln. (155-01941) B. Dioxin Trap Beads ...................................................... 2 • Dioxin Trap Beads (040-27481) 2. Indicators-100 mL brown-glass dropper bottle- C. Active Carbon-impregnated Silica Gel ............................. 2 for titration & pH Measurement ................................. 10 • Activated Carbon-impregnated Silica Gel (019-11941) 3. JCSS Standards ....................................................... 11 2. Endocrine Analysis A. Reagent Kits ............................................................
    [Show full text]
  • Download Download
    International Journal of Biotechnology for Wellness Industries, 2016, 5, 91-110 91 Bioactive Natural Products from Plants and Biotechnological Approaches for their Production Niraj Tripathi, Swapnil Sapre, Iti Gontia-Mishra, Vijay Prakash and Sharad Tiwari* Biotechnology Centre, Jawaharlal Nehru Agricultural University, Jabalpur 482004, India Abstract: Bioactive natural products are economically important as drugs, fragrances, pigments, food additives and pesticides. The biotechnological tools are important to select, multiply, improve and analyze medicinal plants for production of such products. The utilization of medicinal plant cells for the production of natural or recombinant compounds of commercial interest has gained increasing attention over the past decades. Plant tissue culture systems are possible source of valuable medicinal compounds, fragrances and colorants, which cannot be produced by microbial cells or chemical synthesis. In vitro production of bioactive natural products in plant cell suspension culture has been reported from various medicinal plants and bioreactors are the key step towards commercial production. Genetic transformation is a powerful tool for enhancing the productivity of novel products; especially by Agrobacterium tumefacians. Combinatorial biosynthesis is another approach in the generation of novel natural products and for the production of rare and expensive natural products. Recent advances in the molecular biology, enzymology and bioreactor technology of plant cell culture suggest that these systems may become a viable source of important secondary metabolites. Genetic fingerprinting could be a powerful tool in the field of medicinal plants to be used for correct germplasm identification. In addition, when linked to emerging tools such as metabolomics and proteomics, providing fingerprints of the plant’s metabolites or protein composition, it gives data on phenotypic variation, caused by growth conditions or environmental factors, and also yield data on the genes involved in the biosynthesis.
    [Show full text]
  • Drug Metabolism, Pharmacokinetics and Bioanalysis
    Drug Metabolism, Pharmacokinetics and Bioanalysis Edited by Hye Suk Lee and Kwang-Hyeon Liu Printed Edition of the Special Issue Published in Pharmaceutics www.mdpi.com/journal/pharmaceutics Drug Metabolism, Pharmacokinetics and Bioanalysis Drug Metabolism, Pharmacokinetics and Bioanalysis Special Issue Editors Hye Suk Lee Kwang-Hyeon Liu MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editors Hye Suk Lee Kwang-Hyeon Liu The Catholic University of Korea Kyungpook National University Korea Korea Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Pharmaceutics (ISSN 1999-4923) in 2018 (available at: https://www.mdpi.com/journal/ pharmaceutics/special issues/dmpk and bioanalysis) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-916-6 (Pbk) ISBN 978-3-03897-917-3 (PDF) c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editors ..................................... vii Preface to ”Drug Metabolism, Pharmacokinetics and Bioanalysis” ................. ix Fakhrossadat Emami, Alireza Vatanara, Eun Ji Park and Dong Hee Na Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals Reprinted from: Pharmaceutics 2018, 10, 131, doi:10.3390/pharmaceutics10030131 ........
    [Show full text]
  • Acetylcholinesterase
    AChE Acetylcholinesterase Acetylcholinesterase (AChE or acetylhydrolase) is a hydrolase that hydrolyzes the neurotransmitter acetylcholine. AChE is found at mainly neuromuscular junctions and cholinergic brain synapses, where its activity serves to terminate synaptic transmission. It belongs tocarboxylesterase family of enzymes. It is the primary target of inhibition by organophosphorus compounds such as nerve agents and pesticides. AChE has a very high catalytic activity - each molecule of AChE degrades about 25000 molecules ofacetylcholine (ACh) per second, approaching the limit allowed by diffusion of the substrate. ACh is released from the nerve into the synaptic cleft and binds to ACh receptors on the post-synaptic membrane, relaying the signal from the nerve. AChE, also located on the post-synaptic membrane, terminates the signal transmission by hydrolyzing ACh. The liberated choline is taken up again by the pre-synaptic nerve and ACh is synthetized by combining with acetyl-CoA through the action of choline acetyltransferase. www.MedChemExpress.com 1 AChE Inhibitors & Activators (+)-Phenserine (-)-Corynoxidine Cat. No.: HY-16009 Cat. No.: HY-N7010 (+)-Phenserine is a novel selective cholinesterase (-)-Corynoxidine is an acetylcholinesterase noncompetitive inhibitor with an IC50 of 45.3 μM. inhibitor with an IC50 value of 89.0 μM, isolated from the aerial parts of Corydalis speciosa. (-)-Corynoxidine exhibits antibacterial activities against Staphylococcus aureus and methicillin-resistant S. Purity: 98.09% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 5 mg, 10 mg, 50 mg Size: 1 mg, 5 mg (-)-Huperzine A (R)-Rivastigmine D6 tartrate (Huperzine A) Cat. No.: HY-17387 Cat. No.: HY-11017AS (-)-Huperzine A (Huperzine A) is an alkaloid (R)-Rivastigmine D6 tartrate is the deuterium isolated from a Chinese club moss, with labeled (R)-Rivastigmine, which is an neuroprotective activity.
    [Show full text]
  • Toxins and Signalling Evelyne Benoit, Françoise Goudey-Perriere, P
    Toxins and Signalling Evelyne Benoit, Françoise Goudey-Perriere, P. Marchot, Denis Servent To cite this version: Evelyne Benoit, Françoise Goudey-Perriere, P. Marchot, Denis Servent. Toxins and Signalling. SFET Publications, Châtenay-Malabry, France, pp.204, 2009. hal-00738643 HAL Id: hal-00738643 https://hal.archives-ouvertes.fr/hal-00738643 Submitted on 21 May 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Collection Rencontres en Toxinologie © E. JOVER et al. TTooxxiinneess eett SSiiggnnaalliissaattiioonn -- TTooxxiinnss aanndd SSiiggnnaalllliinngg © B.J. LAVENTIE et al. Comité d’édition – Editorial committee : Evelyne BENOIT, Françoise GOUDEY-PERRIERE, Pascale MARCHOT, Denis SERVENT Société Française pour l'Etude des Toxines French Society of Toxinology Illustrations de couverture – Cover pictures : En haut – Top : Les effets intracellulaires multiples des toxines botuliques et de la toxine tétanique - The multiple intracellular effects of the BoNTs and TeNT. (Copyright Emmanuel JOVER, Fréderic DOUSSAU, Etienne LONCHAMP, Laetitia WIOLAND, Jean-Luc DUPONT, Jordi MOLGÓ, Michel POPOFF, Bernard POULAIN) En bas - Bottom : Structure tridimensionnelle de l’alpha-toxine staphylocoque - Tridimensional structure of staphylococcal alpha-toxin. (Copyright Benoit-Joseph LAVENTIE, Daniel KELLER, Emmanuel JOVER, Gilles PREVOST) Collection Rencontres en Toxinologie La collection « Rencontres en Toxinologie » est publiée à l’occasion des Colloques annuels « Rencontres en Toxinologie » organisés par la Société Française pour l’Etude des Toxines (SFET).
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus Chemical Activity Count (+)-ALPHA-VINIFERIN 1 (+)-AROMOLINE 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-HERNANDEZINE 2 (+)-ISOLARICIRESINOL 1 (+)-NORTRACHELOGENIN 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (+)-T-CADINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 1 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-BETONICINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-CANADINE 1 (-)-DICENTRINE 1 (-)-EPICATECHIN 2 (-)-EPIGALLOCATECHIN-GALLATE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 4 Chemical Activity Count 1-ETHYL-BETA-CARBOLINE 2 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 12-(4'-METHOXYPHENYL)-DAURICINE 1 12-METHOXYDIHYDROCOSTULONIDE 1 13',II8-BIAPIGENIN 1 13-HYDROXYLUPANINE 1 13-OXYINGENOL-ESTER 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 16-HYDROXYINGENOL-ESTER 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-METHYLBUT-3-ENE-2-OL 2 2-VINYL-4H-1,3-DITHIIN 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 2 3,3'-DIMETHYLELLAGIC-ACID 1 3,4-DIMETHOXYTOLUENE 2 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 1 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID
    [Show full text]
  • WO 2010/075469 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 1 July 2010 (01.07.2010) WO 2010/075469 Al (51) International Patent Classification: (74) Agent: MEARA, Joseph, P.; Foley & Lardner LLP, 150 C07D 455/03 (2006.01) A61K 31/4741 (2006.01) East Gilman Street, Post Office Box 1497, Madison, WI C07D 495/04 (2006.01) A61P 3/06 (2006.01) 53701 (US). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/US2009/06933 1 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (22) International Filing Date: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, 22 December 2009 (22.12.2009) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (25) Filing Language: English HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (26) Publication Language: English ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (30) Priority Data: NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, 61/140,551 23 December 2008 (23.12.2008) US SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant (for all designated States except US): CVI PHARMACEUTICALS LIMITED [GB/GB]; Scotia (84) Designated States (unless otherwise indicated, for every Centre, 4th Floor, P.O.
    [Show full text]
  • Pharmacological Action of DA-9701 on the Motility of Feline Stomach Circular Smooth Muscle
    ORIGINAL ARTICLES Department of Pharmacology1, College of Pharmacy, Chung-Ang University, Seoul; Department of Oriental Medical Food & Nutrition2, Semyung University, Jecheon-si Republic of Korea Pharmacological action of DA-9701 on the motility of feline stomach circular smooth muscle Thanh Thao Nguyen 1, Hyun Ju Song 1, Sung Kwon Ko 2, Uy Dong Sohn 1 Received February 20, 2014, accepted March 22, 2014 Prof. Uy Dong Sohn, Department of Pharmacology, College of Pharmacy, Chung-Ang University, 84 Heuseok-Ro, Dongjak-gu, Seoul 156-756, Republic of Korea. [email protected] Pharmazie 70: 183–192 (2015) doi: 10.1691/ph.2015.4563 DA-9701, a new prokinetic agent for the treatment of functional dyspepsia, is formulated with Pharbitis semen and Corydalis tuber. This study wasconducted to determine the pharmacological action of DA-9701 and to identify the receptorsinvolved in DA-9701-induced contractile responsesin the feline gastric corporal, fundic and antral circular smooth muscle. Concentration-response curve to DA-9701 was established. The tissue trips were exposed to methylsergide, ketanserin, ondansetron, GR 113808, atropine and dopamine before administration ofDA-9701. The contractile force was determined before and after administration of drugs by a polygraph.DA-9701 enhanced the spontaneous contractile amplitude of antrum, corpus and fundus. However, it did not change the spontaneous contractile frequency of antrum and corpus, but concentration-dependently reduced that of fundus. In the fundus, DA-9701-induced tonic contractions were inhibited by dopamine, methylsergide, ketanserine, ondansetron or GR 113808 respectively, but not by atropine, indicating that the contractile responses are mediated by multiple receptors: 5-HT2, 5-HT3, 5-HT4, and dopamine receptors.
    [Show full text]
  • Introduction (Pdf)
    Dictionary of Natural Products on CD-ROM This introduction screen gives access to (a) a general introduction to the scope and content of DNP on CD-ROM, followed by (b) an extensive review of the different types of natural product and the way in which they are organised and categorised in DNP. You may access the section of your choice by clicking on the appropriate line below, or you may scroll through the text forwards or backwards from any point. Introduction to the DNP database page 3 Data presentation and organisation 3 Derivatives and variants 3 Chemical names and synonyms 4 CAS Registry Numbers 6 Diagrams 7 Stereochemical conventions 7 Molecular formula and molecular weight 8 Source 9 Importance/use 9 Type of Compound 9 Physical Data 9 Hazard and toxicity information 10 Bibliographic References 11 Journal abbreviations 12 Entry under review 12 Description of Natural Product Structures 13 Aliphatic natural products 15 Semiochemicals 15 Lipids 22 Polyketides 29 Carbohydrates 35 Oxygen heterocycles 44 Simple aromatic natural products 45 Benzofuranoids 48 Benzopyranoids 49 1 Flavonoids page 51 Tannins 60 Lignans 64 Polycyclic aromatic natural products 68 Terpenoids 72 Monoterpenoids 73 Sesquiterpenoids 77 Diterpenoids 101 Sesterterpenoids 118 Triterpenoids 121 Tetraterpenoids 131 Miscellaneous terpenoids 133 Meroterpenoids 133 Steroids 135 The sterols 140 Aminoacids and peptides 148 Aminoacids 148 Peptides 150 β-Lactams 151 Glycopeptides 153 Alkaloids 154 Alkaloids derived from ornithine 154 Alkaloids derived from lysine 156 Alkaloids
    [Show full text]
  • United States Patent (19) [11] 3,843,788 Iwasa Et Al
    United States Patent (19) [11] 3,843,788 Iwasa et al. (45 Oct. 22, 1974 54 ANTI-PEPTIC ULCER SUBSTANCE FROM CORYDALISTUBERS (521 U.S. C. ................................................ 424/195 75 Inventors: Junzo Iwasa, Kyoto; Shunsuke 51 int. Cl............................................. A6 k 27/14 Naruto: Noboru Ikeda, both of 58. Field of Search..................................... 424/195 Osaka, Keiji Nakamura, Amagasaki; Yukinobu Sohji, Neyagawa, all of 56 References Cited Japan OTHER PUBLICATIONS 73 Assignee: Dainippon Pharmaceutical Co., Ltd., Evers, “The Chemistry of Drugs," pp. 124-127, Lon Osaka, Japan don: Ernest Benn Limited, (1926), Merck's 1907 Index, (3rd Ed.), p. 159, published by 22 Filed: Oct. 5, 1972 Merck & Co. N.Y. 21 Appl. No.: 295,163 Primary Examiner-Sam Rosen Related U.S. Application Data Attorney, Agent, or Firm-Clelle W. Upchurch 63 Continuation of Ser, No. 62,632, Aug. 10, 1970, abandoned, which is a continuation-in-part of Ser. 57) ABSTRACT No. 735,162, June 7, 1968, abandoned, which is a continuation-in-part of Ser. No. 649, 103, June 27, A method of treating peptic ulcers by oral administra 1967, abandoned, which is a continuation-in-part of tion of an active substance from Corydalis tubers, Ser. No. 493,267, Oct. 5, 1965, abandoned. preferably Corydalis bulbosa D.C., or dehydroco rydaline, compositions therefor and processes for the 30 Foreign Application Priority Data preparation thereof. - Oct. 20, 1964 Japan.............................. 39-0.596.33 2 Claims, No Drawings 3,843,788 2 ANT-PEPTIC ULCER SUBSTANCE FROM Another object of the present invention is to provide CORYDALISTUBERS therapeutic compositions, suitable for the aforesaid method of treatment.
    [Show full text]
  • Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer’S Disease
    molecules Review Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer’s Disease Lucie Cahlíková 1,* , Rudolf Vrabec 2, Filip Pidaný 1, Rozálie Peˇrinová 1, Negar Maafi 1 , Abdullah Al Mamun 1 , Aneta Ritomská 1, Viriyanata Wijaya 1 and Gerald Blunden 3 1 ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; [email protected] (F.P.); [email protected] (R.P.); [email protected] (N.M.); [email protected] (A.A.M.); [email protected] (A.R.); [email protected] (V.W.) 2 Department of Pharmacognosy, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; [email protected] 3 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, Hampshire P01 2DT, UK; [email protected] * Correspondence: [email protected]; Tel.: +420-495-067-311 Abstract: Alzheimer’s disease (AD) is a progressive age-related neurodegenerative disease recog- nized as the most common form of dementia among elderly people. Due to the fact that the exact pathogenesis of AD still remains to be fully elucidated, the treatment is only symptomatic and available drugs are not able to modify AD progression. Considering the increase in life expectancy worldwide, AD rates are predicted to increase enormously, and thus the search for new AD drugs is Citation: Cahlíková, L.; Vrabec, R.; urgently needed. Due to their complex nitrogen-containing structures, alkaloids are considered to be Pidaný, F.; Peˇrinová,R.; Maafi, N.; promising candidates for use in the treatment of AD.
    [Show full text]